Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized law firm headquartered in New York City that specializes in securities fraud class actions and shareholder derivative litigation. The firm represents individual and institutional investors in cases involving violations of federal securities laws, corporate misconduct, and breaches of fiduciary duty. While not a life sciences company itself, the firm is highly active in the biotechnology and pharmaceutical sectors, frequently initiating investigations and filing lawsuits against public companies following clinical trial failures, FDA regulatory setbacks, or misleading financial disclosures. Their primary objective is to recover investment losses for shareholders through aggressive litigation and settlement negotiations. The firm operates primarily on a contingency fee basis, meaning they only receive compensation if they successfully recover funds for their clients.